THERAD 200

THERAD 200 results presentation

CERTIFICATES

ACTING AGENT: X-RAY

TREATMENT METHOD: HIGH, CURATIVE DOSE DELIVERING TO THE SITE OF DISEASE WHILE MINIMIZING THE DOSE DELIVERED TO SURROUNDING HEALTHY TISSUES AND ADJACENT HEALTHY ORGANS

CURE POSSIBILITIES: SITES ON THE DEPTH FROM 0 TO 3 MM FROM THE SKIN SURFACE

ENERGY RANGE: 10-200 keV

MODALITIES: SUPERFICIAL AND ORTHOVOLTAGE

METHOD FEATURES:

• Bloodless;
• Painless;
• Cost-effective;
• One's sheet anchor.

UNIT PERFORMANCE:

• Stationary floor mounted wall supported unit;
• Manually positioning (fast and easy);
• Automatized filter exchanger;
• Autonomous cooling (no additional water consumption);
• 5-10 minutes treatment time;
• up to 100 patients/day.

VALUE:

• DICOM 3 compatible software MedXTera;
• Real time monitoring of the prescribed treatment dose;
• Customized energy selection;
• Leakages for 3 time less than radiation safety require;
• Ergonomic control;
• Electromagnetic brake system;
• Simple, intuitive clinical interface.

APPLICATION VERSATILITY:

Head and neck cancer, non-melanoma skin cancer, vulvar cancer, dermatology.

ONCOLOGY:

• Basal Cell Carcinoma;
• Squamous Cell Carcinoma;
• Kaposi Sarcoma;
• Merkel Cell Carcinoma;
• Bowen’s Disease;
• Mycosis Fungoides;
• Vulvar cancer I stage;
• Bones metastases.

BENIGN CONDITIONS:

• Hidradenitis axillaries;
• Psoriasis;
• Neurodermitis;
• Chronic Eczema;
• Hemangiomas;
• Keloid Scars.

• Peyronie's disease.

INFLAMANTORY DISEASES:

• Arthrosis;
• Bursitis;
• Periarthritis Humeroscapularis;
• Epicondylitis;
• Osteochondrosis;
• Heel Spur;
• Dupuytren’s Contracture.

THERAD

LINEV Group THERAD 200

LINEV Group THERAD 200

LINEV Group THERAD 200